Number of items: 6.
Ahmad, F., Mitchell, R., Houben, T., Palo, A., Yasdati, T., Parnell, A., Patel, K., Shiri-Sverdlov, R. and Leake, D. ORCID: https://orcid.org/0000-0002-1742-6134
(2021)
Cysteamine decreases low density lipoprotein oxidation, causes regression of atherosclerosis and improves liver and muscle function in LDL receptor deficient mice.
JAHA: Journal of the American Heart Association, 10 (18).
ISSN 2047-9980
doi: https://doi.org/10.1161/JAHA.120.017524
Wen, Y., Ahmad, F., Mohri, Z., Weinberg, P. D. and Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134
(2019)
Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
Atherosclerosis, 291.
pp. 9-18.
ISSN 0021-9150
doi: https://doi.org/10.1016/j.atherosclerosis.2019.09.019
Ahmad, F. and Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134
(2019)
Lysosomal oxidation of LDL alters lysosomal pH, induces senescence and increases secretion of pro-inflammatory cytokines in human macrophages.
Journal of Lipid Research, 60.
pp. 98-110.
ISSN 1539-7262
doi: https://doi.org/10.1194/jlr.M088245
Palmer, C., Peri, F., Neumann, F., Ahmad, F., Leake, D. S. ORCID: https://orcid.org/0000-0002-1742-6134 and Pirianov, G.
(2018)
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic
and non-haematopoietic vascular TLR4 signalling.
Innate Immunity, 24 (7).
pp. 411-421.
ISSN 1753-4267
doi: https://doi.org/10.1177/1753425918798904
Ahmad, F. and Leake, D. ORCID: https://orcid.org/0000-0002-1742-6134
(2018)
Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: a possible explanation as to why the clinical trials of antioxidants might have failed.
Chemistry and Physics of Lipids, 213.
pp. 13-24.
ISSN 0009-3084
doi: https://doi.org/10.1016/j.chemphyslip.2018.03.001
Ahmad, F.
(2017)
Lysosomal oxidation of Low Density Lipoproteins.
PhD thesis, University of Reading.
This list was generated on Fri Dec 6 03:57:53 2024 UTC.